Aim Immunotech Inc (AIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2011 | 01-2011 | 12-2010 | 10-2010 | 09-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -866 | 625 | -13,136 | 370 | -10,633 |
| Depreciation Amortization | 218 | 799 | 780 | 404 | 352 |
| Income taxes - deferred | N/A | 556 | N/A | 256 | N/A |
| Accounts receivable | N/A | -1,292 | N/A | -468 | N/A |
| Accounts payable and accrued liabilities | 19 | -173 | 362 | -843 | 763 |
| Other Working Capital | -896 | -3,457 | 608 | -3,062 | -107 |
| Other Operating Activity | -293 | 3,453 | -500 | 2,427 | -445 |
| Operating Cash Flow | $-1,818 | $511 | $-11,886 | $-916 | $-10,070 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -36 | -908 | -729 | -716 | -514 |
| Purchase Of Investment | -3,176 | N/A | -49,889 | N/A | -48,856 |
| Sale Of Investment | 4,522 | N/A | 7,448 | N/A | 4,356 |
| Purchase Sale Intangibles | -147 | N/A | -337 | N/A | -201 |
| Other Investing Activity | -151 | 0 | -346 | 0 | -210 |
| Investing Cash Flow | $1,159 | $-908 | $-43,516 | $-716 | $-45,224 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 0 | 148 | N/A | 968 | 0 |
| Debt Issued | N/A | 6,712 | N/A | 6,712 | N/A |
| Debt Repayment | -14 | -6,301 | -42 | -6,048 | -27 |
| Common Stock Issued | N/A | N/A | 292 | N/A | 293 |
| Financing Cash Flow | $-14 | $559 | $250 | $1,632 | $266 |
| Beginning Cash Position | 2,920 | N/A | 58,072 | 0 | 58,072 |
| End Cash Position | 2,247 | 162 | 2,920 | N/A | 3,044 |
| Net Cash Flow | $-673 | $162 | $-55,152 | $0 | $-55,028 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,818 | 511 | -11,886 | -916 | -10,070 |
| Capital Expenditure | -36 | -908 | -729 | -716 | -514 |
| Free Cash Flow | -1,854 | -397 | -12,615 | -1,632 | -10,584 |